Table 1.
Association between IRGM polymorphisms and inflammatory conditions including cancer
| Meta-analyses | ||||
|---|---|---|---|---|
| Disease | Author | Population | Polymorphism | Association |
| CD | Li et al.[64] | Caucasian | rs13361189 | Increases risk |
| rs10065172, rs4958847 | No association | |||
| Lu et al. [65] | European | rs13361189, rs4958847 and rs10065172 | Increases risk | |
| Tuberculosis | Xie et al. [70] | Asian, African, African-American | rs10065172 (only in Asians), rs4958842, rs4859843 and rs4859846 | Decreases risk |
| rs72553867 | No association | |||
| Case–control and cohort studies | ||||
|---|---|---|---|---|
| Disease | Author | Population | Polymorphism | Association |
| Ankylosing spondylitis | Xia et al. [77] | Han Chinese, female | rs10065172 | No association |
| rs4958846 | Decreases risk | |||
| AITD (Graves’ disease) | Yao et al. [74] | Chinese | rs10065172, rs4958847, and rs13361189 | Increases risk |
| AITD (Hashimoto’s thyroiditis) | rs10065172, rs4958847, and rs13361189 | No association | ||
| Candidiasis in HIV seropositive patients | Rosentul et al. [57] | Tanzanian | rs13361189 and rs4958847 | No association |
| CD | Kee et al. [80] | Malaysian (Malay, Han Chinese, Indian) | rs4958847 | No association |
| rs11747270 A/G | Increases risk | |||
| rs72553867 | No association | |||
| Teimoori-Toolabi et al. [81] | Iranian | rs10065171 and rs4958847 | No association | |
| Pranculienė et al. [82] | Lithuanian | rs4958847 | Increases risk | |
| Na et al. [83] | Korean (Early Onset CD) | rs1000113 | Increases risk | |
| rs72553867 | Decreases risk | |||
| rs13361189, rs4958847 and rs10065172 | No association | |||
| CD fistulising disease | Latiano et al. [67] | Italian | rs4958847 | Increases risk |
| Frequency of CD Ileocolectomy | Sehgal et al. [68] | USA | rs4958847 | Increases risk |
| Complications of postoperative CD Ileocolectomy | Kline et al. [69] | USA | rs13361189 | Increases risk |
| Chronic periodontitis | Folwaczny et al. [76] | German | rs13361189, rs10065172, rs4958847, rs1000113 and rs931058 | No association |
| rs11747270 | Increases risk | |||
| Clear cell renal cell carcinoma | Santoni et al. [62] | Italian | rs10059011 | No association |
| Gastric cancer | Castaño-Rodríguez et al. [49] | Han Chinese | rs4958857 | Decreases risk |
| rs13361189 | Increases risk | |||
| Gastric cancer | Burada et al. [60] | Romanian | rs4958857 | Increases risk |
| rs13361189 | Decreases risk | |||
| Glioma | Ge et al. [61] | NA | rs13361189 | Increases risk |
| rs10065172 | No association | |||
| Hepatic steatosis | Simon et al. [73] | Caucasian (Framingham Heart Study participants) | rs13361189 | No association |
| Leprosy | Yang et al. [75] | Han Chinese | rs13361189 | Increases risk |
| rs4958842 | No association | |||
| Mortality due to severe sepsis | Kimura et al. [79] | Japanese | rs10065172 | Increases risk |
| NAFLD | Lin et al. [84] | Han Chinese (pediatric patients; 6–18 years old) | rs13361189, rs9637876, rs72553867, rs1000113, and rs11747270 | No association |
| rs10065172 | Increases risk | |||
| Tuberculosis | Lu et al. [85] | Chinese | rs10065172, rs10051924 and rs13361189 | Decreases risk |
| Yuan et al. [86] | Han Chinese, Hubei Province | rs4958846 | Decreases risk | |
| rs4958842 and rs4958843 | No association | |||
| Song et al. [87] | Korean | rs10065172 | Decreases risk | |
| rs72553867 and rs12654043 | No association | |||
| Bahari et al. [88] | Iranian | rs4958843 and rs4958846 | Decreases risk | |
| rs4958842 | No association | |||
| King et al. [89] | African-American | rs10065172 | Increases risk | |
| rs11747270 | Increases risk | |||
| UC | Palomino-Morales et al. [78] | Spanish | rs13361189 and rs4958847 | Increases risk |
| VAT and NAFLD in patients presenting with CD | Simon et al. [72] |
Prospective registry in inflammatory bowel Disease study at Massachusetts general hospital (PRISM) cohort |
rs13361189 and rs4958847 | Increases risk |
CD Crohn’s disease; UC ulcerative colitis; NAFLD non-alcoholic fatty liver disease; AITD autoimmune thyroid disease; VAT visceral adipose tissue; HIV human immunodeficiency virus; NA not available